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Abstract
Background: Hypertension affects one billion people globally and is one of the leading risk factors for
cardiovascular and renal diseases. However, hypertension management remains poor, especially in rural China.
Methods: A clustered randomized controlled trial was conducted in six towns in China’s Qianjiang county
between 7/2012 and 6/2014, including 5462 hypertension patients above 35 years old. Six towns were randomly
assigned to three groups: Group 1 had the integrated care model including a multidisciplinary team and
continuous care coordination, Group 2 had both the integrated care model and provider-level financial incentives, and
the control group had the usual care. Primary outcomes were systolic blood pressure and health-related quality of life
measured by SF36; secondary outcomes included hypertension-related hospitalization rate and inpatient spending.
Blood pressure was measured sixteen times bimonthly between 12/1/2011 and 6/30/2014, and quality of life was
measured on 7/1/2012 and 6/30/2014. Inpatient data between 7/1/2010 and 8/31/2014 were used. This trial is
registered at the World Health Organization’s International Clinical Trials Registry, number ChiCTR-OOR-14005563.
Results: We found that the integrated care model effectively lowered blood pressure by 1.93 mmHg (95% CI
0.063–3.8), improved self-assessed health-related quality of life, and reduced the rate of hypertension-related
hospitalization by 0.17 percentage points (95% CI 0.094–0.24). We also found that the provider-level financial
contract further lowered blood pressure by 1.76 mmHg (95% CI 0.73–2.79) and reduced rates of hospitalization
and inpatient spending, but it also reduced patients’ self-assessed health-related quality of life.
Conclusions: Integrated care and financial incentives are effective in lowering blood pressure and reducing
hospitalization rate, but financial contracts may hurt patient quality of life.
This trial was registered at the Chinese Clinical Trial Registry (ChiCTR-OOR-14005563) on November 23, 2014.
It was a retrospective registration.
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Background
As the burden of disease has shifted from acute illness
to chronic diseases worldwide, patients’ needs require
more continuous care coordination and integration
across multiple professional providers. However, in the
current healthcare delivery system, patients often ex-
perience fragmented medical care, and the fragmenta-
tion of care has become one of the major challenges
many countries face [1, 2]. To reform the fragmented
system, new integrated care models, with or without
new funding models, are being tried out around the
world, including American Accountable Care Organiza-
tions, Australian Primary Health Networks, British
Integrated Care Pioneers, and the Germany’s Gesundes
Kinzigtal model [1, 3, 4].
Healthcare is particularly fragmented in rural China,
where the healthcare system includes three tiers: village,
town, and county [5]. Patients go to village clinics for
simple outpatient care and preventive care, and go to
town hospitals or county hospitals for inpatient care or
outpatient conditions village clinics cannot handle.
Communications among multiple professional providers
are limited and there are virtually no document sharing
and interactions among providers across the three tiers.
Thus, an integrated care model shows particular promise
for improving care in China. However, no large-scale in-
terventions have been conducted to test alternative
chronic-care models that integrate care across providers
and across tiers in rural China.
Some new integrated care models being tested out in
western countries include a new funding component in
which providers can share savings if spending falls below
a pre-specified financial benchmark. There is some early
evidence showing that these types of financial incentives
are associated with potential savings in total healthcare
costs [3, 4, 6]. However, in general, fewer studies have
evaluated effects of provider-level financial incentives on
chronic care management, especially through random-
ized control trials [7, 8].
In this study, we conducted a multi-town clustered
randomized trial on hypertension management in rural
China. Six towns were randomly assigned to three
groups: Group 1, with the integrated care model includ-
ing a multidisciplinary team and continuous care coord-
ination; Group 2, with both the integrated care model
and provider-level financial incentives; and a control
group, with usual care.
Patients in our study sample had been diagnosed with
hypertension for at least 6 months and had three or
more measures of blood pressure greater than 140/
90 mmHg in the Chinese national official medical record
before our interventions began. Hypertension is preva-
lent, affecting nearly one billion people worldwide and
over 442 million people in China [9, 10]. It is one of the
leading risk factors for cardiovascular and renal diseases
and is estimated to cause 12.8% of total deaths world-
wide and 20% of deaths in China [9, 10]. In China, the
proportion of patients with hypertension unaware of
their conditions was over 30% and the proportion of
known hypertensive patients who received treatment
was only 56.1% in 2012 [11, 12]. The rate of uncon-
trolled blood pressure (defined as blood pressure greater
than 140/90 mmHg) among Chinese with hypertension
is much higher than in the West, estimated to be 78.3%
in 2008 and 63.4% in 2012 [11, 13]. In addition, inequal-
ity in hypertension management is prevalent in China:
poor or rural residents were much less likely to receive
treatment, compared to those living in urban or affluent
areas [11]. For all these reasons, there are potentially
large health gains from validating better hypertension
treatment models in rural China.
Previous studies have found that inadequate control of
hypertension is often related to gaps in continuity of
health care [10], poor adherence to medications [14],
and unhealthy lifestyle [10], and integrated care can im-
prove hypertension management [15]. For example,
Glynn and colleagues reviewed 72 clinical trials designed
to improve hypertension management in primary care
settings and concluded that patients benefited from an
organized system of regular patient follow-up and a
multidisciplinary team to improve coordination of care
[15]. An integrated healthcare delivery system in north-
ern California has demonstrated an effective program to
manage hypertension, often considered as best practice
[16]. This program includes a comprehensive hyperten-
sion registry, standardization of blood pressure mea-
surements, an evidence-based treatment algorithm, and
a multidisciplinary team including medical assistants,
nurses, and pharmacists [16]. Several recent review
articles note that multidisciplinary team-based care for
hypertension management consistently results in im-
proved blood pressure [17–20], and may be cost-
effective [21].
Our work therefore builds upon evidence from previ-
ous studies, but two contributions of our study are espe-
cially distinctive: First, to our knowledge, this is the first
large-scale randomization to study integrated care and
provider financial incentives in China. We therefore pro-
vided some first-hand evidence of how the integrated
care model and the financial contract can be incorpo-
rated in less developed areas where inadequate medical
resources, fragmented care, and poor quality of care are
prevalent. Second, previous interventions were often
randomized at clinic or provider level, while as we relied
on a distinctive randomization at the town level. This
design choice is important because it enables us to
evaluate the integration across village-town-county tiers
in rural China, for the first time.
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Methods
Study setting and usual care
Our intervention sites were in Qianjiang county, a typical
rural area that is 280 km to the south east of Chongqing,
one of the largest cities and one of four municipalities in
China. Qianjiang has a population of 550,000 people, with
an average annual income per capita of under USD480 for
the past 5 years [22]. Qianjiang has 30 communities, 24 of
which are rural towns and the remaining six are urban
districts (Fig. 1). The average town population is approxi-
mately 18,000, and each town consists of around 10
villages.
Rural residents obtain their health insurance through
the New Rural Cooperative Medical Scheme, which
provides health insurance for 627 million Chinese rural
residents, accounting for 46% of the total Chinese
population as of 2014 [23]. Rural residents seek care
from a village-town-county three-tier healthcare deliv-
ery system. A typical village has one clinician with lim-
ited medical care training, who provides patient
education, simple outpatient care and preventive care
to all villagers. The village clinic, sometimes in the cli-
nician’s home, has a small supply of medications but
often lacks rudimental medications that are included in
the national essential medicine list. There are no hospi-
tals in the villages. Each town has one hospital and
rural residents go to town hospitals for inpatient care
and outpatient care that the village clinic is not
equipped to handle.
If town hospitals cannot treat the patient’s illness, the
patient goes to county or city hospitals. Under the
current system, in most areas, patients can also go to
county or city hospitals directly without going through
town hospitals, but the inpatient reimbursement rate is
much lower for services provided in county or city hos-
pitals compared to town hospitals. For example, in 2012
in Qianjiang, the inpatient policy reimbursement rate
was 70% for services provided in town hospitals and 55%
in county hospitals. The actual effective reimbursement
rate in county hospitals was even lower, about 44% in
2012, because many services provided in county hospi-
tals were not eligible for reimbursement. Regardless of
where rural residents in Qianjiang seek their inpatient
care (town, county or city), the reimbursable portion of
the medical care is paid with social health insurance
pooled at Qianjiang county level. The gross costs of an
inpatient stay in a county hospital can easily double the
cost in town hospitals for the same procedure, and the
difference in costs between city and county hospitals is
even larger. Residents are incentivized to seek care in
lower level hospitals because of their lower gross costs
and higher reimbursement rate.
Interventions
We tested two new care components: the integrated care
model started on Aug 1, 2012, and the financial incen-
tive contract started on Jun 1, 2013, (because it took
some time to negotiate contracts), in comparison with
usual care. Both interventions ended on Jun 30, 2014.
We conducted a clustered randomized controlled trial
with two intervention groups (Group 1 and Group 2)
and a control group (usual care). Group 1 only received
the integrated care model, while Group 2 received both
the integrated care model and the financial incentives.
Thus, we use Group 1 to test the improvements in inte-
grated care that could be made within the current fund-
ing model, and Group 2 to test the additional effects of
the financial incentives.
Integrated care model
Our integrated care model for chronic conditions has
two important features: one is to combine treatment and
prevention care with a multidisciplinary team; the other
is to provide continuous care coordination across the
village-town-county three-tier delivery system.
Fig. 1 Geographic Locations of Six Towns. Notes: Intervention Group
1 consisted of Jinxi and Apengjiang; intervention Group 2 consisted
of Zhuoshui and Shihui; and the control group consisted of Shijia
and Fengjia. Sources: authors created it
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Multidisciplinary team
Each patient in our sample potentially has a team of 27
providers, consisting of 23 clinicians and four non-
clinical staff. The team includes the patient’s village clin-
ician (each village only has one clinician), two physicians
(one outpatient and one inpatient) and four non-
clinicians (three chronic disease coordinators/educators,
and one case manager) at the town hospital (each town
hospital has three to four physicians and four non-
clinician staff to treat patients with hypertension), and
20 clinicians at the county hospitals. Qianjiang has two
public county-level hospitals; from each hospital, we en-
rolled ten doctors: two outpatient physicians and three
inpatient physicians from each of the two departments:
neurology and cardiology. Each country hospital has
about 16 to 20 doctors to treat hypertension patients.
Continuous care coordination
We designed three mechanisms through which con-
tinuous care could be effectively provided to patients.
First, patient medical records, lab results, and other
health related documents were shared among all par-
ticipating providers. Second, each month, county doc-
tors gave lectures to township clinicians on how to
diagnose and treat patients with hypertension and con-
ducted case reviews on selected patients. Town doctors
then provided monthly lectures and discussed cases
with village doctors. The group learning was recorded
by the case manager and assessed later by the grant
project manager. Third, we categorized four different
types of clinical pathways depending on the severity of
hypertension (Appendix). In each pathway, we specified
clear guidelines on definitions of severity, on measure-
ments town physicians should provide before referring
to county clinicians, and on what county clinicians
could and could not do based on the reports from vil-
lage and town providers.
Financial contracts
A contract was signed with each of two towns in Group
2 on Jun 1, 2013. The contract clearly stated that if at
the end of the performance year, the total actual in-
patient spending for all patients with hypertension in
Group 2 towns was above the benchmark amount, the
providers who participated in the trial would be paid
according to the regular reimbursement schemes; how-
ever, if the total actual inpatient spending was below
the predicted benchmark amount, they would obtain a
bonus at 60% of total savings.1 The provider team is re-
sponsible for the total actual inpatient spending for all
patients in the Group 2 towns, regardless whether the
patients seek care at town, county or city hospitals.
Thus, healthcare providers cannot reduce cost through
patient selection. Because inpatient spending is much
higher in upper-level hospitals than lower-level hospi-
tals, providers have incentives to encourage patients to
use lower-level hospitals.
Randomization at the town level
The head of the Department of Health in Qianjiang
identified six out of 24 rural towns as feasible for this
type of interventions, according to population size, so-
cioeconomic development, and capacity levels of medical
facilities. We divided the six towns equally into two
clusters: one cluster of three towns with a smaller
population, lower socioeconomic development levels,
poorer hospital quality, and further distance away from
the county center; and the other cluster with contrast-
ing characteristics. In each cluster, we randomly
assigned three towns to Groups 1, 2 and the control
group. If a town was selected, all villages in the town
were automatically selected for the study. Figure 1
shows the geographic locations of 6 towns and Table 1
compares towns’ basic characteristics that were sur-
veyed in Jul 2012.
Randomization at the patient level
We obtained the entire list of patients residing in the six
towns who had been officially registered as a chronic pa-
tient with hypertension in the national chronic disease
database between Jan 1, 2008, and Jan 1, 2012. Not
everyone with hypertension was registered during this
period. Having a national official medical record means
that these patients were aged 35 and over, had a history
of hypertension for at least 6 months, had blood pres-
sure recorded at least four times a year, and had at least
three measures of blood pressure greater than 140/
90 mmHg. Our list includes 5,789 patients. We obtained
all of their inpatient claim data between Jan 1, 2010, and
Dec 31, 2014.
To collect more person-level blood pressure, health re-
lated quality of life, and life style information through
in-person in-house survey, we randomly selected 300 pa-
tients from each town, because we did not have re-
sources to interview all 5789 patients. We stratified a
random sample on the basis of three variables: gender
(female and male), age (35–60, 61+), and risk level of
hypertension (high, medium, and low). Using these three
variables, we stratified 12 mutually exclusive subgroups
per town and selected patients by subgroup. Before ran-
dom sampling, we excluded patients who: 1) had a
stable blood pressure history (consistently under 120/
80 mmHg) for longer than 1 year because they did not
need to take medications; 2) were estimated for a life
expectancy less than 2 years due to old age, vegetative
state or severe complications such as cerebral infarction
or pancreatic cancer; 3) were considered to be difficult
to follow up because they were away for over 6 months
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a year due to migration for work, education or caring
for family; and 4) were unable to complete surveys due
to intellectual incompetence, mental damage or inabil-
ity to communicate.
Among 1800 randomly-sampled patients, 1641 pa-
tients agreed to participate and conducted the baseline
interview (91.2%), but only 1408 had valid complete
baseline survey data (85.8%), 1,245 (75.9%) of which also
completed the end-point interview and had valid data.
The response rate was relatively high because village cli-
nicians who know patients well accompanied the inter-
viewers to patient homes and subjects were provided
some household staples (toothpastes, soap, etc.) as gifts
if they agreed to participate in the study.
Data sources and outcomes
We used three main data sources: inpatient claims data
for all 5,789 patients, patient-level survey data and
blood pressure measures from the national chronic
condition management registry database for 1,245 ran-
domly selected patients. Inpatient data did not include
death information, so we obtained death information
from the Qianjiang Health Bureau but we could not get
death records before 2012.
For patient-level survey data, we had two points: one
measured at the baseline on Jul 1, 2012, and the other
measured at the end-point on Jun 30, 2014. Systolic
blood pressure was measured bimonthly between Dec 1,
2011, and Jun 30, 2014, for four times in the baseline
period and 12 times post interventions.
In order to test each intervention and because in-
patient data is highly volatile, we consolidated inpatient
data into ten 5-month periods between Jul 1, 2010, and
Aug 31, 2014: five periods in the baseline before inter-
vention 1, two periods between interventions 1 and 2,
and three periods after intervention 2. For those who
died during our intervention period, we followed them
up until they died. The unit of observations is person-
period. For each person-period, we calculated three out-
comes to measure hypertension related hospitalization:
rates of hospitalization (1 = any hypertension related in-
patient stay; 0 = otherwise), likelihood of using a county/
city hospital, and total gross inpatient spending. We define
hypertension related hospitalization as hospitalization re-
lated to hypertension as well as other conditions for which
hypertension is a risk factor, including cardiovascular dis-
eases and stroke.
Health related quality of life was measured with in-
house surveys using the Medical Outcome Study Short-
Form 36-Item Health Survey (SF36 Scale) that was devel-
oped by the RAND Corporation Health Insurance Experi-
ment [24]. In reporting results, we primarily focused on
three summary scores: SF36 physical health, psychological
health, and total scores. Some subjects had missing values
on these variables, so we only had 1,082 subjects with
both baseline and end-point measurements.
Covariates
Covariates included age, gender, family structure (living
alone, with spouse, with children only, with spouse and
children, or with others), education (no education,
elementary and middle school, high school and above),
average annual income, average annual medical expend-
iture, salt and fat control, and self-assessed competence in
treatment adherence. These were collected through in-
person surveys at both baseline and the end-point.
Statistical analyses
We plotted the trend in blood pressure by group for all
16 measures we have between Dec 2011 and Jun 2014
(Fig. 2). Baseline comparisons on other measures were
Table 1 Comparison of Characteristics Used to Randomly Assign Six Towns To Three Groups, July 2012
Intervention Group 1 Intervention Group 2 Control Group
Apengjiang Jinxi Zhoushui Shihui Fengjia Shijia
Number of residents 28,000 15,600 27,055 22,448 27,464 14,126
Annual average income per capita (CNY) 6452 5417 6487 5452 6900 5031
Distance to county (minutes) 50 90 30 60 25 100
Medical facility revenue (CNY10K) 265 169 279 198 311 159
Notes: These basic characteristics were surveyed in July 2012 and used to randomly assign towns to the three groups. We first divided the six towns equally into
two clusters: one cluster of three towns with a smaller population, lower socioeconomic development levels, poorer hospital quality, and further distance away
from the county center (Jinxi, Shihui, and Shijia); and the other cluster with contrasting characteristics. In each cluster, we randomly assigned three towns to
Groups 1, 2 and the control group, respectively
Fig. 2 Trend in Unadjusted Systolic Blood Pressure by Group
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undertaken by Chi-squared test for categorical variables
and one-way analysis of variance for continuous vari-
ables. Because towns in our intervention groups faced
considerable amount of administrative pressures to
lower systolic blood pressure to below 140 mmHg, they
had initiated some strategies to lower blood pressure be-
fore our interventions started. These strategies included
providing free medications, imposing more rigid super-
vision of village doctors, and designating someone in the
town hospital to manage chronic conditions. At the start
of our interventions, however, these strategies were
stopped as a result of our negotiations with participating
towns’ administration team. Figure 2 shows that the con-
trol group had a different baseline trend from the inter-
vention groups in the 8 months leading to our
interventions, but blood pressure levels across three
groups became comparable at the beginning of our
interventions.
We used difference-in-differences models to test the
effects of both interventions simultaneously. Specifically,
we included the post intervention 1 indicator (≥Aug 1,
2012), the indicator for being exposed to intervention 1
(individuals in group 1 and group 2), their interaction
term, the post intervention 2 indicator (≥Jun 1, 2013),
the indicator for being exposed to intervention 2 (indi-
viduals in group 2), and their interaction term. Our vari-
ables of interest are the two interaction terms, which
represent the marginal effects of the two interventions.
Because the baseline trends in blood pressure before
our interventions were different between intervention
groups and the control group, to avoid overestimating
the intervention effects on blood pressure, we included
linear bi-month time trends in the model. In addition,
we also conducted sensitive analyses to only use data
points between Jun 2012 and Jun 2014, and report this
as our primary results as lower bound. The model also
included individual fixed effects to control for unob-
served characteristics within individuals and time fixed
effects.
For health-related quality of life, we estimated a simi-
lar difference-in-differences model that included the post
intervention indicator, the indicator for being exposed to
intervention 1, the indicator for being exposed to inter-
vention 2, and the two interaction terms between post
intervention indicator and intervention exposure indica-
tors. The model also controlled for individual fixed ef-
fects and time-variant covariates mentioned above.
For three outcomes on hypertension related hospi-
talizations, we conducted three separate models; in
each model, we controlled for time and town fixed
effects, and used individual random effects instead of
individual fixed effects, because many individuals had
zero inpatient visits. First, we used logistic regression
models to estimate the intervention effects on rates of
hospitalization. Second, to estimate the utilization rate for
town or county/city hospitals, we adopted a two-part
model which consisted of two logistic regressions: we first
estimated the rate of having any hospital stays and then
estimated the rate of using county/city hospitals condi-
tioning on having any hospital stays. Third, we evaluated
the effect on inpatient spending using a two-part model:
first, we estimated the use of hospitalization with a logistic
regression, and second, we estimated effects on inpatient
spending conditional on having an inpatient stay using a
generalized linear model with gamma distribution and
logarithm link. We then estimated the marginal effects
and the standard errors of the interaction terms using
bootstrap [25].
The project protocol was approved by the Tongji
Medical College Academic Ethics Committee of
Huazhong University of Science and Technology in
China (IORG No: IORG0003571). This trial is registered
at the Chinese Clinical Trials Registry (ChiCTR-OOR-
14005563).
Results
Table 2 compares individual characteristics at the July
2012 baseline across three groups and shows that most
characteristics are comparable. Individuals in Group 1
were slightly more educated and had higher self-assessed
competence in treatment adherence compared to those
in the other two groups. Individuals in Group 1 had
slightly poorer health measured by SF36 scores com-
pared to the control group, but health in Group 1 and
Group 2 was similar. There was no statistically signifi-
cant difference in overall health between Group 2 and
the other two groups.
Table 3 shows the estimated effects of interventions
on the level of systolic blood pressure from two
difference-in-differences models, one with data points
between Dec 2011 and Jun 2014 and the other between
Jun 2012 and Jun 2014 as our primary results to be more
conservative.
Relative to the control group, the integrated care
model was associated with a 1.93 mmHg (95% CI 0.063–
3.8; p < 0.001) reduction in systolic blood pressure, or
1.3% of the pre-intervention level at 149.3 mmHg. Rela-
tive to the integrated care model, financial incentives
were associated with an additional 1.76 mmHg (95% CI
0.73–2.79; p < 0.001) reduction in systolic blood pres-
sure, or 1.2% of the pre-intervention level.
Figure 3 shows the estimated results on health-related
quality of life. Integrated care improved health outcomes
measured by SF36 scores: it increased physical health by
11.4 points, psychological health by 9.5 points, and over-
all health by 10.8 points. However, the intervention of
provider-level financial incentives was associated with a
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worse self-assessed health-related quality of life: overall
health is lowered by 8.06 points.
Table 4 shows the effects of interventions on three
outcomes on hypertension-related hospitalization:
hospitalization rate, likelihood of using a county hos-
pital, and total spending. As mentioned above, inpatient
data were aggregated per person every 5 months. In the
baseline period from Jul 1, 2010, to Jul 31, 2012, the
average rate of hypertension-related hospitalization per
person per 5 months was 1.9% in Group 1 and Group
2, and 1.8% in the control group.
We observed a consistent pattern that both interven-
tions resulted in lower rates of hypertension-related
hospitalization. Specifically, the integrated care model
reduced the rate of hospitalization by 0.17 percentage
points (95% CI 0.094–0.24), or 8.9% from the baseline
1.9 percentage points per person every 5 months in
Group 1 and 2 (Table 4 Column 1). The financial incen-
tives further reduced the rate of hospitalization by 0.096
percentage points (95% CI 0.029–0.16), or 5.1% from the
Group 2 baseline level (Table 4 Column 2).
The likelihood of using a county level hospital in-
creased slightly due to integrated care but did not
change with additional financial incentives. Inte-
grated care was associated with a slight increase in
total inpatient spending, by $9.40 (95% CI 6.16–
12.64) per person every 5 months, or 13.3% from
the baseline 70.89. This can be partially explained by
more use of county level hospital instead of town
hospitals because gross costs in the former more
than doubled gross costs in the latter. Financial in-
centives were associated with lower total inpatient
spending, by $5.21 (95% CI 2.55–7.86), or 7.9% from
the baseline 65.68 in Group 2.
Table 2 Comparison of Characteristics by Group at the Baseline, July 2012
Variables Group 1 Group 2 Control Group 1-Control Group 2-Control Group 1-Group 2
Age 64.5 66.5 65.5 −0.9 1.1 −2.0
Female, % 51.9 54.2 55.9 −4.0 −1.7 −2.2
Family structures, %
Living alone 14.4 16.0 14.6 −0.2 1.3 −1.5
Living with spouse only 34.3 32.8 36.9 −2.7 −4.2 1.5
Living with kids only 13.4 17.6 17.3 −3.9 0.4 −4.2
Living with both spouse and kids 35.8 32.8 28.8 7.0 4.0 3.1
Other family structure 2.1 0.8 2.4 −0.3 −1.6 1.2
Education, %
No education 32.4 37.2 39.6 −7.2 −2.4 −4.8
Attend elementary school 45.8 48.5 44.4 1.4 4.1 −2.7
Attend high school or above 21.9 14.3 16.1 5.8 −1.8 7.6
Average annual income, ¥ 5540 6797 5405 135 1392 −1257
Personal annual medical expenditure, ¥ 1854 1689 1891 −37 −202 165
Salt control 3.5 3.4 3.3 0.2 0.2 0.0
Fat control 3.7 3.5 3.6 0.1 0.0 0.2
Self-assessed competence to treatment adherence 75.4 71.8 70.7 4.7 1.1 3.6
SF36 Physical health 45.4 47.3 50.5 −5.1 −3.1 −1.9
SF36 Psychological health 48.3 50.8 52.8 −4.5 −2.0 −2.5
SF36 Total Score 47.8 50.1 52.5 −4.7 −2.4 −2.3
Notes: Bold denotes significant at p-value < 0.05. The values of salt control and fat control are 1 = never, 2 = occasional, 3 = sometimes, 4 = often, 5 = always;
self-assessed competence to treatment adherence is between 0 and 100, with a larger number indicating higher competence; and the values of SF scores are
between 0 and 100, with a larger number indicating better health
Table 3 Effects of Interventions on Systolic Blood Pressure from
the Difference-in-differences Model
(1) (2)
Integrated Care Model −4.77*** −1.93**
(0.85) (0.95)
Financial Contract Model −1.59*** −1.76***
(0.56) (0.53)
No. of observations 19,965 16,221
Time Trend Yes Yes
Data starting time Dec/2011 Jun/2012
Notes: This table shows the marginal effects of the two interventions using a
difference-in-differences model. Individual fixed effect and linear time trends
are included to adjust for the non-parallel pre-intervention trend. Robust
standard errors are in parentheses; *** denotes p < 0.01, ** denotes p < 0.05
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Discussion
We found that the integrated care model effectively low-
ered blood pressure, improved self-assessed health-
related quality of life, and reduced the rates of
hypertension-related hospitalization, but we did not find
that the integrated care model reduced total inpatient
spending, partially because integrated care increased the
use of county-level hospitals instead of town hospitals.
We also found that the provider-level financial contract
further lowered blood pressure and reduced rates of
hospitalization and inpatient spending, but it also re-
duced patients’ self-assessed health-related quality of life.
These results are encouraging, given over half of
hypertensive patients currently have uncontrolled blood
pressure globally [11, 26, 27]. Our interventions lowered
systolic blood pressure, to an extent on the lower
spectrum of findings in previous studies [15, 17, 18, 20,
28, 29]. Our observed effects are small for two main rea-
sons: first, our interventions target on healthcare system
delivery changes, which may take a long time to realize
effects. Second, subjects in our study had much higher
baseline blood pressure than those in previous studies
and therefore are more difficult to treat, However, for
subjects in our study, even a small reduction in blood
pressure could result in meaningful effects on lowering
hospitalizations and cardiovascular risk. Indeed, we ob-
served that interventions reduced the rate of cardiovas-
cular related hospitalization. A recent meta-analysis
reviewed nineteen clinical trials and confirmed the
effects of lowering blood pressure on reducing major
cardiovascular events, myocardial infarction, stroke, al-
buminuria, and retinopathy progression [30]. More im-
portantly, our subjects are mainly farmers, and physical
health has large and direct effects on their income, and
therefore the improved hypertension control has more
economic impact which is not measured here.
It is interesting to observe that provider-level financial
incentives are associated with reductions in patient self-
Fig. 3 Effects of Interventions on Quality of Life Measured by Three SF36 Scores. Notes: This table shows the marginal effects of the two
interventions using a difference-in-differences model. All SF36 scores range between 0 and 100, with larger numbers indicating better life quality.
Individual fixed effects are included. Robust standard errors are in parentheses; *** denotes p <0.01, ** denotes p <0.05
Table 4 Marginal Effects of Interventions on Overall Hospitalization
Rate, Rate of Using Upper Level Hospitals, and Inpatient Spending
for Hypertension Related Hospitalization, Bootstrapping Results






Hospitalization rate −0.00167*** −0.000955***
(0.000373) (0.000338)




Total inpatient spending 9.398*** −5.208***
(1.654) (1.354)
No. of observations 57,890 57,890
Notes: Robust standard errors are in parentheses; *** denotes p < 0.01, and
* denotes p < 0.1. All models included fixed effects for town and time period,
as well as individual random effect
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assessed quality of life. When provider payments are
aligned with total inpatient spending, providers may dis-
courage patients from using hospital services, especially
more expensive services in higher-level hospitals. If pa-
tients do not trust their doctors, which is very common
in China, patients may think they were not provided the
best medical treatment and thus feel worse about their
own health or simply report worse health than they
perceive.
Our study is not without limitations. First, the finan-
cial contract in Group 2 was not fully executed. By de-
sign, the potential bonus to providers was tied with
outcome-based performance measures and savings in
total inpatient spending in the town. However, in reality,
the assessment on performance was weak and not fully
monitored. Second, our interventions were conducted in
one county in China, and therefore results may not be
generalizable to other areas. However, Qianjiang county
is highly representative of China’s rural areas, in terms of
its population size, mobility, economic development
state, and prevalence rates of chronic diseases. In
addition, we obtained our patient list from the national
chronic disease registry for hypertension, and patients
officially registered in the registry were sicker than gen-
eral patients ever diagnosed with hypertension.
Conclusions
Because our study groups were randomly assigned, our
findings are guarded against some selection biases that
are common in other recent evaluations of integrated
care models that were conducted through observational
data [3, 4]. Taken together, our findings have important
clinical and policy implications on how to better manage
chronic conditions. First, the integrated care model sub-
stantially lowered blood pressure and improved patients’
health. Our findings support changing from the current
fragmented care model to the more integrated,
multidisciplinary-team-based care model, even in the
current funding model. This result is consistent with
other integrated care models that are being tried out in
other countries. Second, continuous care coordination
across provider disciplines and village-town-county tiers
was important; so was sharing medical records among
providers and developing continuous quality improve-
ment processes. Third, combining integrated care with a
new funding model further reduced blood pressure and
inpatient spending, but also reduced patients’ quality of
life. This suggests that financial incentives should not be
too quickly introduced in rural China without further
evaluations.
Because the relatively low costs (USD25K) and poten-
tial savings to conduct the interventions, it is feasible to
roll out the integrated care model to other rural areas in
China more broadly. Most rural areas in China have the
financial ability to support such a new delivery model.
The key to the success is the central government’s will-
ingness to try and the local administration team’s leader-
ship to implement it.
In sum, the integrated care model and the financial
contract are effective in lowering blood pressure and re-
ducing rates of hypertension-related hospitalization. In-
tegrated care is also associated with better health-related
quality of life. However, the long-term savings in health-
care costs from these models remain to be seen.
Endnotes
1During the intervention period, the operations of the
social health insurance in Qianjiang were reorganized
from county level to city level and the Qianjiang county
health bureau no longer had authority to change the re-
imbursement policy. As a result, although the contract
stated a bonus to be 60% of the savings, the actual bonus
at the end of the project was set by the head of the
Qianjiang administrative office as CNY70K (USD10,654)
per town in Group 2, and it was actually paid through
the research grant to be shared among 23 clinicians and
four non-clinical staff. However, during the intervention
period, providers were not aware of this change, so they
were still subject to the incentives in the contracts.
Appendix
Four types of clinical pathways in the integrated care model
Type A for which patients first sought care in their vil-
lage clinics, was a minor condition that could be treated
by village clinicians. If the condition did not improve,
patients were referred to town hospitals. Type B was an
emergency case, defined as instant blood pressure ≥ 180/
120 mmHg, and if blood pressure was not reduced by
25% within an hour, the patient was admitted to the
emergency room. Type C was a complex and serious
condition with complications, defined by the following
criteria: 1) instant blood pressure ≥ 180/120 mmHg; 2)
severely damaged target organs; and/or 3) other cardio-
vascular, cerebrovascular and circulatory system compli-
cations. Once village or town doctors identified a Type B
or C patient, they had to contact their corresponding
county hospital clinicians and transfer the patient to
the relevant county hospital department. During the
inpatient stay, county doctors needed to monitor the
patient status and also followed up after inpatient dis-
charge. Type D patients were newly identified patients
with hypertension and had a visit directly in a county
hospital without going through the clinical pathway.
Once a type D patient was identified, the patient was
enrolled in our integrated care pathway system, and the
county provider contacted the local village clinician to
start a new medical record for the patient.
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